Nasdaq stss.

NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company ...Nov 16, 2023 · Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery company offering patented, best-in-class syringe products, announced today a new partnership focused on developing and sharing best practices in innovative manufacturing, product development, customer support, and quality as ... STSS Sharps Technology Inc. 0.80-0.0099 (-1.22%) After Hours. Last Updated: 17:40:18. Delayed by 15 minutes ...Feb 1, 2023 · In connection with the offering, the Company will issue 2,248,521 units and pre-funded units at a purchase price of $1.69 per unit priced at-the-market under Nasdaq rules.

NASDAQ: Sharps Technology Inc (STSS) = 0.47 USD. Provided by Alpha Vantage. Sharps Technology Inc stock (STSS) in USD. 1 STSS = 0.47 USD. 1 month. 6 months. 1 year. 5 years. Hold over 40 currencies to convert and send money at any time. Open an account. Sharps Technology Inc stock performance at a glance. Check Sharps Technology Inc’s …

NEW YORK, Feb. 06, 2023 (GLOBE NEWSWIRE) — Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering patented, best-in-class syringe products, today announced that it closed its previously announced private placement pursuant to a securities …NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company ...

Sharps Technology (NASDAQ:STSS) Monday filed a prospectus related to the proposed resale of 11.33 million common shares by the selling stockholders.This prospectus is not an offer to sell these ...STSS Sharps Technology Inc Sharps Technology Signs Asset Purchase Agreement to Acquire InjectEZ Specialty Copolymer Syringe Manufacturing Facility and a 10-Year Purchase Agreement for Over $400Stock. Equities. Stock Sharps Technology, Inc. - Nasdaq. Sharps Technology, Inc. (STSS.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and …US82003F1012. Sharps Technology, Inc. is a medical device and pharmaceutical packaging company, which engages in the development and manufacturing of innovative drug delivery systems. It also focuses on low waste, and ultra-low waste syringe technologies that incorporate both passive and active safety features.

NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company ...

Robert Hayes, CEO of Sharps Technology, Inc. (NASDAQ: STSS), delves into what Sharps does, what exciting developments have transpired such as their major dis...

In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. What are individual investors saying about Sharps Technology? View the latest STSS social media trends at MarketBeat.STSS Sharps Technology Inc Sharps Technology Appoints Industry Sales and Manufacturing Leader Ben Scheu as Senior Director of SalesNEW YORK, July 06, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering ...NEW YORK, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company ...Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like they did in the case of Sharps Technology, Inc. (NASDAQ:STSS), that sends out a ...

Sep 29, 2023 · STSS Sharps Technology Inc Form 8-K - Current report. Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Sharps Technology Inc. Common Stock (STSS) Advanced Charting - Nasdaq offers advanced charting & market activity data for US and global markets.Sharps Technology stock was originally listed at a price of $2.11 in Apr 14, 2022. If you had invested in Sharps Technology stock at $2.11, your return over the last 1 years would have been -77.73%, for an annualized return of -77.73% (not including any dividends or dividend reinvestments).Sep 29, 2023 · STSS Sharps Technology Inc Form 8-K - Current report. Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of ... Feb 1, 2023 · STSS Sharps Technology Inc Sharps Technology Announces Pricing of $3.8 Million Private Placement Priced at the Market NEW YORK, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the 'Company', 'Sharps') (NASDAQ: 'STSS' and 'STSSW'), an innovative medical device and drug delivery Company offering patented, ... NEW YORK, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering ...

NEW YORK, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company ...

Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering patented, best-in-class syringe products, announces an update on commercialization activities and is highlighted in Med Tech Outlook feature article.View real-time STSS stock price and news, along with industry-best analysis. ... Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet, Dow Jones. ETF Movers: Includes ETFs & ETNs with ...Nov 24, 2023 · Sharps Technology (STSS) Insider Trading Activity 2023. S&P 500 4,559.34. DOW 35,390.15. QQQ 389.51. Turned down for a loan, business owners look to family and even crowdsourcing to get money to grow. [Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad) 12 crew members are missing, 1 dead after a cargo ship sinks off ... Apr 19, 2022 · The common stock and warrants began trading on The Nasdaq Capital Market on April 14, 2022, under the symbols “STSS” and “STSSW,” respectively. Aegis Capital Corp. acted as the sole book ... Medical device firm Sharps Technology ( NASDAQ: STSS) said on Wednesday in a letter to shareholders that it was in a position to manufacture and deliver 100 million units of syringe products over ...Jul 12, 2023 · STSS Sharps Technology Inc Sharps Technology Appoints Industry Sales and Manufacturing Leader Ben Scheu as Senior Director of Sales Key appointment with demonstrated experience in leading sales and marketing operations to oversee commercial initiatives as the Company launches its specialty smart safety syringe products to the mark... https://sharpstechnology.com. Sharps Technology, Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications.STSS Sharps Technology Inc Statement of Changes in Beneficial Ownership (4) FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.

Sharps Technology stock was originally listed at a price of $2.11 in Apr 14, 2022. If you had invested in Sharps Technology stock at $2.11, your return over the last 1 years would have been -77.73%, for an annualized return of -77.73% (not including any dividends or dividend reinvestments).

Nasdaq: STSS. Price. $0.47. December 1, 2023 3:59 PMETDecember 1, 2023. Volume ... NASDAQ Capital Market : STSS. Sharps Technology Inc. (STSS). $0.470.00(0.04 ...

At Cannae Holdings, a filing with the SEC revealed that on Monday, Director Barry B. Moullet bought 1,000 shares of CNNE, for a cost of $23.06 each, for a total investment of $23,064. So far ...STSS: Get the latest Sharps Technology stock price and detailed information including STSS news, historical charts and realtime prices. Gainers Unique Fabricating, Inc. (NYSE: UFAB) climbed 205% to $0.55 after gaining around 4% on Tuesday. ...Maybe you’ve never invested before. Maybe you have no clue what the difference is between NASDAQ and the New York Stock Exchange. Regardless, the name Charles Schwab probably rings a bell.Sep 27, 2023 · NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company ... NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company ...NEW YORK, July 14, 2022 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device company offering patented, best-in-class ...The latest price target for . Sharps Technology (NASDAQ: STSS) was reported by Aegis Capital on Tuesday, May 9, 2023.The analyst firm set a price target for 16.00 expecting STSS to rise to within ...NEW YORK, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company ...

The common stock and warrants began trading on The Nasdaq Capital Market on April 14, 2022, under the symbols “STSS” and “STSSW,” respectively. Aegis Capital Corp. acted as the sole book ...https://sharpstechnology.com. Sharps Technology, Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications.NASDAQ: Sharps Technology Inc (STSS) = 0.47 USD. Provided by Alpha Vantage. Sharps Technology Inc stock (STSS) in USD. 1 STSS = 0.47 USD. 1 month. 6 months. 1 year. 5 years. Hold over 40 currencies to convert and send money at any time. Open an account. Sharps Technology Inc stock performance at a glance. Check Sharps Technology Inc’s …Sharps Technology Inc. Common Stock (STSS) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.Instagram:https://instagram. best stock options advisory servicedog elon marspatterson companies stockvxx share NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company ... vatican news pope francisbest books on investing for beginners Sharps Technology has extensive expertise in specialized prefilled syringe systems and ready to use processing. The company has a manufacturing facility in Hungary and has partnered with Nephron ...Sharps Technology Announces Closing of $5.6 Million Registered Direct and Private Placement. NEW YORK, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, … leading wealth management firms Nov 10, 2023 · Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.. On July 12, 2023, Sharps Technology, Inc. (the “Company”) received a notice (the “Notice”) from the staff of the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it was not in compliance with Nasdaq ... NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) — Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, today announced that it has entered into a definitive agreement with institutional investors for …